TABLE IV.
Group | Nanomaterial | Ligand type | Max. PA signal elapse (H) | Half lifetime (h) | Mean residence time (h) | Major features |
---|---|---|---|---|---|---|
Huang et al.99 | PEG-Sn-ONc | PEG | 24 | 5.6 ± 1.2 | 8.1 ± 1.8 | • = 930 nm |
• 4 times longer half-life | ||||||
• ∼10 times AUC. | ||||||
Jia et al.101 | HSA-FePc NPs | Human serum albumin | 12 | ⋯ | ⋯ | • = ∼ 44.4% (at 671 nm) |
• = 55 nm | ||||||
• = −26.9 mV | ||||||
• Low long-term toxicity | ||||||
• Preferential accumulation to tumor site | ||||||
• ∼51.3 wt% loading efficiency |